Search by Drug Name or NDC
NDC 65862-0872-25 Latanoprost 50 ug/mL Details
Latanoprost 50 ug/mL
Latanoprost is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is LATANOPROST.
MedlinePlus Drug Summary
Latanoprost ophthalmic is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision) and ocular hypertension (a condition which causes increased pressure in the eye). Latanoprost is in a class of medications called prostaglandin analogs. It lowers pressure in the eye by increasing the flow of natural eye fluids out of the eye.
Related Packages: 65862-0872-25Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Latanoprost Ophthalmic
Product Information
| NDC | 65862-0872 |
|---|---|
| Product ID | 65862-872_54d2f142-0d56-44f0-9997-72dcc00bfcb0 |
| Associated GPIs | 86330050002020 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Latanoprost |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Latanoprost |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | ug/mL |
| Substance Name | LATANOPROST |
| Labeler Name | Aurobindo Pharma Limited |
| Pharmaceutical Class | Prostaglandin Analog [EPC], Prostaglandins [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206519 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65862-0872-25 (65862087225)
| NDC Package Code | 65862-872-25 |
|---|---|
| Billing NDC | 65862087225 |
| Package | 1 BOTTLE in 1 CARTON (65862-872-25) / 2.5 mL in 1 BOTTLE |
| Marketing Start Date | 2019-09-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |